EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Controlled Hookworm Infection for Medication-free Maintenance in Patients with Ulcerative Colitis: A Pilot, Double-blind, Randomized Control Trial

Thomas C Mules iD, Brittany Lavender, Kate Maclean, Francesco Vacca, Sophia-Louise Noble, Bibek Yumnam, Tama Te Kawa, Alissa Cait, Jeffry Tang, David O'Sullivan, Olivier Gasser, James Stanley und 3 weitere

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izad110 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Thomas C Mules und 14 weiteren Autor:innen. Beteiligte Einrichtung: Malaghan Institute of Medical Research, Wellington, New Zealand. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Quality of Life, Hookworm Infections, Feces. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health Research Council of New Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human hookworm has been proposed as a treatment for ulcerative colitis (UC). This pilot study assessed the feasibility of a full-scale randomized control trial examining hookworm to maintain clinical remission in patients with UC.

Methods

Twenty patients with UC in disease remission (Simple Clinical Colitis Activity Index [SCCAI] ≤4 and fecal calprotectin (fCal) <100 ug/g) and only on 5-aminosalicylate received 30 hookworm larvae or placebo. Participants stopped 5-aminosalicylate after 12 weeks. Participants were monitored for up to 52 weeks and exited the study if they had a UC flare (SCCAI ≥5 and fCal ≥200 µg/g). The primary outcome was difference in rates of clinical remission at week 52. Differences were assessed for quality of life (QoL) and feasibility aspects including recruitment, safety, effectiveness of blinding, and viability of the hookworm infection.

Results

At 52 weeks, 4 of 10 (40%) participants in the hookworm group and 5 of 10 (50%) participants in the placebo group had maintained clinical remission (odds ratio, 0.67; 95% CI, 0.11-3.92). Median time to flare in the hookworm group was 231 days (interquartile range [IQR], 98-365) and 259 days for placebo (IQR, 132-365). Blinding was quite successful in the placebo group (Bang’s blinding index 0.22; 95% CI, −0.21 to 1) but less successful in the hookworm group (0.70; 95% CI, 0.37-1.0). Almost all participants in the hookworm group had detectable eggs in their faeces (90%; 95% CI, 0.60-0.98), and all participants in this group developed eosinophilia (peak eosinophilia 4.35 × 10^9/L; IQR, 2.80-6.68). Adverse events experienced were generally mild, and there was no significant difference in QoL.

Conclusions

A full-scale randomized control trial examining hookworm therapy as a maintenance treatment in patients with UC appears feasible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeQuality of LifeHookworm InfectionsFecesMesalamineRemission InductionHumansMaleDouble-Blind MethodFemalePilot ProjectsAdultMiddle AgedAnimalsLeukocyte L1 Antigen ComplexTreatment OutcomeFeasibility Studies

Stichwörter der Autor:innen

clinical trialhelminthhookworminflammatory bowel diseaseulcerative colitis

Substanzen

MesalamineLeukocyte L1 Antigen Complex

Autor:innen und Institutionen

  • Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Department of Medicine, Otago University, Wellington, New Zealand.
  • Biostatistics Group, Otago University, Wellington, New Zealand.

ORCID-Profile: Thomas C Mules

Förderung

  • Health Research Council of New Zealand

Zitieren

APA

Mules, T. C., Lavender, B., Maclean, K., Vacca, F., Noble, S. L., Yumnam, B., Te Kawa, T., Cait, A., Tang, J., O'Sullivan, D., Gasser, O., Stanley, J., Le Gros, G., Camberis, M., & Inns, S. (2024). Controlled Hookworm Infection for Medication-free Maintenance in Patients with Ulcerative Colitis: A Pilot, Double-blind, Randomized Control Trial. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad110

Vancouver

Mules TC, Lavender B, Maclean K, Vacca F, Noble SL, Yumnam B, et al. Controlled Hookworm Infection for Medication-free Maintenance in Patients with Ulcerative Colitis: A Pilot, Double-blind, Randomized Control Trial. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad110

BibTeX
@article{Mules2024,
  author = {Mules, Thomas C and Lavender, Brittany and Maclean, Kate and Vacca, Francesco and Noble, Sophia-Louise and Yumnam, Bibek and Te Kawa, Tama and Cait, Alissa and Tang, Jeffry and O'Sullivan, David and Gasser, Olivier and Stanley, James and Le Gros, Graham and Camberis, Mali and Inns, Stephen},
  title = {Controlled Hookworm Infection for Medication-free Maintenance in Patients with Ulcerative Colitis: A Pilot, Double-blind, Randomized Control Trial},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izad110}
}
Kostenlos starten →